DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. (INO) slipped 3.21% to $1.51 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.18% to 21,057.96 and the Dow Jones Industrial Average falling 0.70% to 44,693.91.
The stock's fall snapped a six-day winning streak.
Inovio Pharmaceuticals Inc. closed 87.75% below its 52-week high of $12.33, which the company achieved on July 26th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.27% to $169.56, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE.AU)$ fell 0.04% to $25.35.
Trading volume (1.3 M) remained 530,963 below its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 24, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 24, 2025 17:27 ET (21:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.